{"title":"KRAS突变驱动的增强型巨噬细胞：利用白蛋白作为传递纳米药物的特洛伊木马。","authors":"Drishti Rathod, Mukti Vats, Poonam Gawali, Osaretin Otagho, Bhoomi Dholariya, Ketan Patel","doi":"10.1080/17435889.2025.2524312","DOIUrl":null,"url":null,"abstract":"<p><p>Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS), the most mutated oncogene, drives tumoral progression by leveraging macropinocytosis. This nutrient uptake pathway is responsible for promoting the relentless growth of KRAS-mutant tumoral cells while also unlocking a new frontier for the exploration of innovative therapeutic approaches. Leveraging KRAS-driven macropinocytosis, researchers are instigating advanced nanoparticulate drug delivery systems, including albumin nanoparticles and DNA- and RNA-loaded lipid nanoparticles. We emphasize the emerging strategies to exploit KRAS-macropinocytosis-albumin crosstalk presenting a promising avenue for the delivery of albumin nanoparticles in cancer therapy.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1759-1773"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239804/pdf/","citationCount":"0","resultStr":"{\"title\":\"KRAS mutation-driven enhanced macropinocytosis: using albumin as a trojan horse for delivering nanomedicine.\",\"authors\":\"Drishti Rathod, Mukti Vats, Poonam Gawali, Osaretin Otagho, Bhoomi Dholariya, Ketan Patel\",\"doi\":\"10.1080/17435889.2025.2524312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS), the most mutated oncogene, drives tumoral progression by leveraging macropinocytosis. This nutrient uptake pathway is responsible for promoting the relentless growth of KRAS-mutant tumoral cells while also unlocking a new frontier for the exploration of innovative therapeutic approaches. Leveraging KRAS-driven macropinocytosis, researchers are instigating advanced nanoparticulate drug delivery systems, including albumin nanoparticles and DNA- and RNA-loaded lipid nanoparticles. We emphasize the emerging strategies to exploit KRAS-macropinocytosis-albumin crosstalk presenting a promising avenue for the delivery of albumin nanoparticles in cancer therapy.</p>\",\"PeriodicalId\":74240,\"journal\":{\"name\":\"Nanomedicine (London, England)\",\"volume\":\" \",\"pages\":\"1759-1773\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239804/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanomedicine (London, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17435889.2025.2524312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2025.2524312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
KRAS mutation-driven enhanced macropinocytosis: using albumin as a trojan horse for delivering nanomedicine.
Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS), the most mutated oncogene, drives tumoral progression by leveraging macropinocytosis. This nutrient uptake pathway is responsible for promoting the relentless growth of KRAS-mutant tumoral cells while also unlocking a new frontier for the exploration of innovative therapeutic approaches. Leveraging KRAS-driven macropinocytosis, researchers are instigating advanced nanoparticulate drug delivery systems, including albumin nanoparticles and DNA- and RNA-loaded lipid nanoparticles. We emphasize the emerging strategies to exploit KRAS-macropinocytosis-albumin crosstalk presenting a promising avenue for the delivery of albumin nanoparticles in cancer therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
